Logistics companies play a key role in delivering investigational drugs and materials to clinical trial sites, an essential part of new drug development.[1] Clinical trial delivery is a highly regulated and complex system that must adhere to strict global regulatory standards including Good Manufacturing Practice (GMP), Good Clinical Practice (GCP) and Good Distribution Practice (GDP).[1] This process involves multiple stages—manufacturing, packaging, labeling, distribution, and storage—each of which must ensure patient safety and data integrity.[1] Logistics chains face challenges such as managing complex international logistics, maintaining the stability of products during transport and complying with various regulatory requirements in individual countries.[1] Comprehensive planning, continuous risk assessment and proactive communication between all stakeholders are recommended to optimize the supply chain.[1] Technologies such as automated tracking and predictive analytics can improve operational efficiency and ensure timely delivery of drugs to trial sites.[1]